Pay in 4 interest-free payments of $5.36 Learn more
Ships within 48 hours · Estimated delivery Aug 15 - Aug 20
Metsera has a portfolio of therapeutic candidates and combinations with four programs in clinical development and several next-generation programs with IND-enabling studies ongoing, aimed at addressing key unmet needs via fewer injections while achieving improved efficacy and tolerability
Recognizing these issues early and responding appropriately improves outcomes
Additionally, large biologic molecules have limited permeability through cell membranes, necessitating advanced delivery systems such as lipid nanoparticles (LNPs) and viral vectors
159 RaymanM
Personalized treatment plans: Care is tailored to your biology rather than a generic formula
US$ 26.10
US$ 20.86
US$ 28.10
US$ 29.95
US$ 25.66
US$ 29.73
US$ 26.11
US$ 26.64
US$ 25.87
US$ 24.13
US$ 22.21
